Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis
-
- Hata Reo
- Department of Cardiology, Kurashiki Central Hospital
-
- Oka Naoki
- Department of Cardiology, Kurashiki Central Hospital
-
- Kubo Shunsuke
- Department of Cardiology, Kurashiki Central Hospital
-
- Kuwayama Akimune
- Department of Cardiology, Kurashiki Central Hospital
-
- Ohya Masanobu
- Department of Cardiology, Kurashiki Central Hospital
-
- Shimada Takenobu
- Department of Cardiology, Kurashiki Central Hospital
-
- Miura Katsuya
- Department of Cardiology, Kurashiki Central Hospital
-
- Amano Hidewo
- Department of Cardiology, Kurashiki Central Hospital
-
- Hyodo Yusuke
- Department of Cardiology, Kurashiki Central Hospital
-
- Otsuru Suguru
- Department of Cardiology, Kurashiki Central Hospital
-
- Habara Seiji
- Department of Cardiology, Kurashiki Central Hospital
-
- Tada Takeshi
- Department of Cardiology, Kurashiki Central Hospital
-
- Tanaka Hiroyuki
- Department of Cardiology, Kurashiki Central Hospital
-
- Fuku Yasushi
- Department of Cardiology, Kurashiki Central Hospital
-
- Goto Tsuyoshi
- Department of Cardiology, Kurashiki Central Hospital
-
- Kadota Kazushige
- Department of Cardiology, Kurashiki Central Hospital
Search this article
Abstract
<p>Background:Little is known about the impact of stent type on the prognosis of vasospastic angina (VSA) in patients who undergo stent implantation.</p><p>Methods and Results:We evaluated consecutive patients undergoing coronary angiography with positive (n=650; VSA) and negative (n=2,872; non-VSA) ergonovine testing. Among them, 304 patients undergoing stent implantation for organic stenosis were classified for comparison into 3 respective VSA and non-VSA groups based on stent type (68 and 78 with bare-metal stent [BMS]; 21 and 49 with sirolimus-eluting stent [SES]; 26 and 62 with newer generation drug-eluting stent [N-DES]). The primary outcome was defined as target lesion revascularization, target vessel revascularization, emergency coronary angiography, and cardiac death. The 2-year cumulative incidence of the primary outcome was significantly higher in the VSA group than non-VSA group after SES implantation (38.1% vs. 16.1%, P=0.03), whereas there were no differences between the 2 groups after both BMS implantation and N-DES implantation. The difference in the percent diameter stenosis from mid-term to late-term follow-up was significantly higher in the VSA group than non-VSA group (10.0% vs. 2.3%, P=0.045) after SES implantation, whereas there were no differences between the 2 groups after both BMS implantation and N-DES implantation.</p><p>Conclusions:The impact of VSA on clinical and angiographic outcomes was observed only in SES implantation, but not after N-DES or BMS implantation.</p>
Journal
-
- Circulation Journal
-
Circulation Journal 82 (2), 469-476, 2018
The Japanese Circulation Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205106238592
-
- NII Article ID
- 130006321832
-
- NII Book ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL BIB ID
- 028782188
-
- PubMed
- 28659551
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed